Paul W. Schaffer's most recent trade in Panbela Therapeutics Inc. was a trade of 12,368 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 25, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc. | Paul W. Schaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 12,368 | 12,368 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Paul W. Schaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 4,316 | 166,671 (2%) | 0% | 0 | Common Stock | |
| Panbela Therapeutics Inc. | Paul W. Schaffer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,875 | 162,295 (2%) | 0% | 0 | Common Stock | |
| Panbela Therapeutics Inc. | Paul W. Schaffer | Director | Purchase of securities on an exchange or from another person at price $ 2.51 per share. | 04 Sep 2020 | 24,775 | 159,195 (2%) | 0% | 2.5 | 62,158 | Common Stock |
| Panbela Therapeutics Inc. | Paul W. Schaffer | Director | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 04 Sep 2020 | 225 | 159,420 (2%) | 0% | 2.6 | 574 | Common Stock |